Amphotericin B for Frogs: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Amphotericin B is a prescription polyene antifungal. It binds to sterols in fungal cell membranes and damages the fungus so it cannot survive. In veterinary medicine, it is best known as a strong antifungal reserved for serious infections because it can also affect normal tissues, especially the kidneys in species where systemic absorption occurs.

In frogs, amphotericin B is not a routine at-home medication. Your vet may consider it only in selected exotic or amphibian cases, usually when a fungal disease is severe, unusual, or not responding to more commonly used topical protocols. For chytridiomycosis caused by Batrachochytrium dendrobatidis (Bd), current amphibian references more often discuss topical itraconazole, terbinafine, temperature management when species-appropriate, and strict enclosure disinfection, because systemic antifungals have generally been less effective for this skin-based disease.

Because frogs absorb substances through their skin, medication safety can vary widely by species, life stage, hydration status, water chemistry, and whether the drug is given as a bath, topical treatment, or injection. That is why amphotericin B should only be used under the direction of a veterinarian experienced with amphibians or exotic pets.

In frogs, amphotericin B may be considered for serious fungal disease when your vet believes the likely organism could respond to this drug. That can include some internal or disseminated mycoses discussed in amphibian medicine references, where treatment choices are limited and prognosis depends heavily on how advanced the disease is.

It is sometimes mentioned as an alternative antifungal in amphibian research, including work on chytridiomycosis. However, available evidence suggests amphotericin B may reduce fungal burden without reliably clearing infection in naturally infected frogs, so it is not usually the first medication discussed for Bd. For many frogs with chytrid disease, your vet is more likely to talk through topical antifungal baths, supportive care, hydration, thermal support when safe for the species, and environmental decontamination.

Your vet may also use amphotericin B as part of a broader plan rather than as a stand-alone answer. That plan can include PCR testing, skin cytology or histopathology, fluid support, quarantine, enclosure sanitation, and repeat monitoring to see whether the frog is improving clinically and whether fungal load is falling.

There is no single universal amphotericin B dose for all frogs. Published amphibian references describe dosing that varies by route and clinical goal, and many uses are off-label. One amphibian formulary reference lists 1 mg/kg intracelomic every 24 hours for internal mycoses, but that kind of dosing should never be attempted outside direct veterinary supervision because amphibians are highly sensitive to hydration changes, handling stress, and medication errors.

For chytridiomycosis specifically, research has evaluated 15 micrograms/mL amphotericin B exposure in naturally infected southern leopard frogs and found reduced infection intensity, but not complete fungal clearance. That is an experimental finding, not a home-treatment recipe. In practice, your vet must decide whether a bath, topical protocol, or systemic route makes sense for your frog's species, size, disease stage, and water balance.

If your vet prescribes amphotericin B, ask exactly how the drug should be prepared, how long exposure should last, whether gloves are needed, what water or buffer to use, and how the enclosure should be disinfected during treatment. Small differences in concentration, contact time, and solution chemistry can matter a lot in amphibians.

Never estimate a frog's dose from dog, cat, reptile, fish, or human instructions. Frogs are not small mammals, and even a tiny measuring error can become dangerous.

Side effects depend on how amphotericin B is given and how much of the drug is absorbed. In general veterinary medicine, amphotericin B is known for dose-dependent kidney toxicity. In frogs, that risk matters because sick amphibians can already be dehydrated or osmotically unstable, which may make them less able to tolerate aggressive antifungal therapy.

Call your vet promptly if your frog seems more lethargic, stops eating, loses weight, sheds excessively, develops worsening skin changes, becomes weak, shows abnormal posture, or declines during treatment. These signs can reflect the underlying fungal disease, medication intolerance, dehydration, or a combination of problems.

With any bath or topical antifungal protocol in amphibians, your vet also watches for stress during handling, skin irritation, worsening fluid balance, and species-specific sensitivity. If systemic amphotericin B is used, your vet may recommend monitoring hydration status and, when feasible, kidney-related lab values or other follow-up testing.

Do not stop or change the medication plan on your own unless your vet tells you to. In frogs, abrupt changes in treatment or enclosure conditions can make a fragile patient worse.

The biggest interaction concern with amphotericin B is additive kidney stress. In veterinary medicine, amphotericin B is more likely to cause problems when it is combined with other potentially nephrotoxic drugs. That includes medications such as aminoglycoside antibiotics and some other drugs that can reduce kidney perfusion or worsen dehydration.

In frogs, interaction data are limited, so your vet usually takes a cautious approach. Be sure to tell your vet about all medications, supplements, water additives, disinfectants, and recent treatments, including antibiotics, antifungals, electrolyte products, and any over-the-counter products used in the enclosure.

Drug interactions in amphibians are not always well studied. That means your vet may avoid combining amphotericin B with other medications unless there is a clear reason, or may space treatments out and monitor more closely if combination therapy is necessary.